Gardasil, Cervarix Could Be Approved This Year In Japan
This article was originally published in PharmAsia News
Executive Summary
Gardasil and Cervarix, cervical cancer vaccines manufactured by Merck and GlaxoSmithKline, respectively, could be approved for use this year in Japan